Hospital - innovation - economics
The Assistance Publique-Hôpitaux de Paris (AP-HP) and the Paris School of Economics (PSE) have created mid-2014 hospinnomics. This research chair aims at getting together economists for them to have an impact on decision-making, and aims at developing evaluation and experimental methods to maximize the available resources in the service of patients.
To visit the dedicated website : http://www.hospinnomics.eu/
The collaboration of two institutions
Hospinnomics is born under the will and meeting of two personalities:
- Martin Hirsch, Director of the AP-HP, who wanted to launch an academic structure in health economics, in order to document decisions taken in terms of organisation and investments, as they condition efficiency, equity and costs of access of patients cared for by AP-HP.
- Pierre-Yves Geoffard, Director of the PSE, who wanted to keep on opening economics research to other fields and bringing it closer to decision-makers and general audience; the Institut des Politiques Publiques and the Esther Duflo’s J-PAL both illustrate this.
A dual objective is targeted by AP-HP and PSE: on one hand, to develop academic research that will have an impact on decision-making, and on the other hand to contribute towards more evidence-based decisions in the health sector. The experience shows that this ambition is relevant, but hard to reach. Early 2014, a large benchmark study has been conducted and helped to frame the constraints and key success factors.
The Chair hospinnomics
Hospinnomics is a research Chair hosted by the Paris School of Economics and located at the Hôtel-Dieu hospital.
Lise Rochaix, Scientific Director of the chair, will be in charge of pursuing the 4 hospinnomics objectives:
- Broad dissemination
As for its governance, the Chair relies on its Scientific Counsel that gathers seven economists, all professors in foreign Universities. It is presided by Pierre Corvol, Collège de France professor.
The thematic programme of hospinnomics is twofold. First, evaluation methods of technological and organisational innovations will be conducted; for example, experimental evaluations will be implemented in the health sector – say to evaluate the impact of prevention campaigns. Second, there will be a focus on regulation : tarifs, measures of inequality, incentives… For example, the Chair will analyse the variations of the residual costs due by the patients depending on his/her treatment (lenght, steps…).
Partnership and context
Resources are put together by AP-HP and PSE for the next 3 years. However, hospinnomics could increasingly be developed thanks to other institutions and universities – some of which have already shown interest in such a partnership.
Hospinnomics will also interact with french and international actors in health economics, such as the Dauphine health chair and the Imperial College; it will also strenghten the links with other fields related to health (epidemiology, medicine, public health, data science, social sciences…).